Antiverse is building a world-first computational antibody drug discovery platform. They combine in-house lab expertise with state of the art machine learning to predict antibody-antigen binding and provide antibody drug candidates in one day.

Status current

Associated Fund UK Innovation & Science Seed Fund

Sector Medical / Biotechnology


Associated Team Members


HMRC Statistics reveal another record breaking year for EIS !

EIS garners record-breaking backing yet again! In our recent blogs, we have been running...

read more

What part have Midven played in the MEIF hitting the...

What is MEIF and where do Midven come in? It has been over a...

read more

More Companies in Medical / Biotechnology

Your browser is out-of-date!

Update your browser to view this website correctly.Update my browser now